However, MxA is only one of many hundreds of genes that are upregulated by IFN-α, and thus the observations that a small subset of patients given IFN-α develop PAH may reflect the actions of these myriad of other changes in IFN-treated vascular tissues in addition to upregulation of MxA. The gene discussed is IFNA2; the disease is pulmonary arterial hypertension.